Atossa Therapeutics Announces Plans to Pursue Metastatic Breast Cancer Indication for (Z)-Endoxifen and Continued Engagement with FDA on Additional Indications

0
13
Atossa Therapeutics, Inc. announced its strategic decision to pursue a metastatic breast cancer indication for (Z)-endoxifen.
[Atossa Therapeutics, Inc.]
Press Release